Reduces healing time 1,2
right from the start , with it's interactive healing matrix

EFFECTIVE

EXPLORER RCT proves the sooner UrgoStart treatment is initiated, the better the outcome.

•71% of wounds completely healed after 20 weeks of treatment

•Reduced healing time by 60 days on average

Use from day one to
complete healing, through
all healing phases (apart
from dark necrosis)
3

Proven to be cost effective,
right from the start 

SAVE ON

TREATEMENT COSTS

The UrgoStart treatment range gives you better outcomes AND saves on treatment costs.

You generate significant savings per patient due to reduced healing time, reduced dressing changes and nursing time & reduced complications.

THE

TEAM

ACCOLADES

An Innovation with a

High Level of Recognition

Recognition by the HAS
(French Health Care Authorities), France

August, 2018

PUBLICATION

of Explorer

in the Lancet Diabetes & Endocrinology

March, 2018

"Innovation Team Best Practices" AWARD, La Sorbonne, France

September, 2018

The NICE GUIDANCE:

“TLC-NOSF to Treat DFU & VLUS”, UK
January, 2019

The "Prix Galien"  AWARD, France
December, 2018

International Working Group on Diabetic Foot Guidelines***
May, 2019

The “Most Innovative Product” JWC AWARD
March, 2019

"Innovative

Health Solution" PRIZE, Spain

July, 2018

KEEP CONNECTED

At UrgoStart Plus we continue to evaluate our ideas,

enhance our skills and gain access to the most

cutting-edge technologies. 
 

Newsletter Icon UrgoStart Plus.png

Sign up for a quarterly NEWSLETTER.  

Learn about our latest products and technologies.

Talk To Icon UrgoStart Plus.png

Request a starter pack.

SPEAK WITH

your account manager

1. Münter KC, Meaume S, Augustin M, Senet P, Kérihuel J.C. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC NOSF wound dressings. J Wound Care. 2017 Feb; 26 ( S4 S15. Erratum in: J Wound Care. 2017 Mar 2; 26(3): 153.

 

2. Edmonds M, Lázaro Martínez JL, Alfayate García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186 196.*. |

 

3. Sigal ML, Addala A, Maillard H, Chahim M, Sala F, Blaise S, Dalac S, Meaume S, Bohbot S, Tumba C, Tacca O. Clinical evaluation of a new TLC NOSF dressing with poly absorbent fibers for the local management of exuding leg ulcers, at the different stages of the healing process: Results from two multicentric, single arm, prospective, open label clinical trials. J Wound Care 2019: 28(3) 3):164 175

 

URGO Medical North America, 3801 HulenSt. Ste 251, Fort Worth,

TX 76107

Urgo Medical Logo.png

1-888-446-4143

  • Urgo Medical
  • UrgoStart Plus

Copyright © 2020 UrgoStart Plus. All Rights Reserved. Website by willowgraphix.com